Our Story
From Research to Real-World Application
Aerobyx was founded to advance research originating at the University of Kansas Medical Center, focused on cellular energy and neurodegeneration. This work explores how restoring mitochondrial function may change the trajectory of the disease.
Why This Work Matters
Alzheimer’s remains one of the leading causes of death without a therapy that can stop or reverse disease progression. The need for new approaches is urgent.
Our Focus
Aerobyx is committed to:
Advancing science grounded in research
Exploring new approaches to complex diseases
Translating discovery into potential therapies
We’re focused on advancing our research and building a foundation for future development.